Enovis (ENOV) Non-Current Debt (2010 - 2026)
Enovis (ENOV) reported Non-Current Debt of $1.3 billion for Q2 2026, down 5.6% year-over-year from $1.4 billion in Q2 2025, and up 2.31% quarter-over-quarter from $1.3 billion in Q4 2025.
Enovis (ENOV) Non-Current Debt (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Non-Current Debt data on file, last reported at $1.3 billion in Q2 2026.
- Non-Current Debt for Q2 2026 came in at $1.3 billion, down 5.6% year-over-year; the trailing twelve-month figure through Apr 2026 was $1.3 billion (down 5.6% YoY), and the FY2025 annual result was $1.3 billion, down 3.64% from the prior year.
- Non-Current Debt improved to $1.3 billion in Q2 2026 per ENOV's latest filing, from $1.3 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $1.6 billion in Q2 2022 and troughed at $40.0 million in Q4 2022.
- A 5-year average of $1.0 billion and a median of $1.3 billion in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2023: Non-Current Debt sank 98.08% in 2022, then jumped 1065.41% in 2023.
- A 5-year view of Non-Current Debt shows it stood at $40.0 million in 2022, then jumped by 1065.41% to $466.2 million in 2023, then jumped by 180.9% to $1.3 billion in 2024, then dropped by 3.64% to $1.3 billion in 2025, then gained by 2.31% to $1.3 billion in 2026.
- Business Quant data shows ENOV's Non-Current Debt at $1.3 billion in Q2 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.29 Bn |
| Apr 3, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Oct 3, 2025 | 1.34 Bn |
| Oct 3, 2025 | 1.34 Bn |
| Jul 4, 2025 | 1.37 Bn |
| Jul 4, 2025 | 1.37 Bn |
| Apr 4, 2025 | 1.37 Bn |
| Apr 4, 2025 | 1.37 Bn |
| Dec 31, 2024 | 1.31 Bn |
| Dec 31, 2024 | 1.31 Bn |
| Sep 27, 2024 | 1.33 Bn |
| Sep 27, 2024 | 1.33 Bn |
| Jun 28, 2024 | 1.33 Bn |
| Jun 28, 2024 | 1.33 Bn |
| Mar 29, 2024 | 1.32 Bn |
| Mar 29, 2024 | 1.32 Bn |
| Dec 31, 2023 | 466.16 Mn |
| Dec 31, 2023 | 466.16 Mn |